doi: 10.1055/s-0042-109065 Summary Keywords diabetes mellitus type 2, cardiovascular disease, cardiovascular risk, diabetic kidney disease, sodium-glucose cotransporter-2 inhibitor, glucagon-like peptide-1 receptor agonist, aldosterone, renin Citation Puglisi S, Rossini A, Poli R, Dughera F, Pia A, Terzolo M and Reimondo G (2021) Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Renin-Angiotensin-Aldosterone System

Contact your GP or diabetes specialist nurse within 24-48 hours if: Headaches are progressively worsening over days or weeks despite simple measures The pattern of headaches changes significantly from your usual experience Headaches are severe enough to interfere with daily activities or are not responding to standard analgesics You experience persistent visual disturbances , even without other neurological symptoms (note that the Ozempic SmPC warns about potential worsening of diabetic retinopathy, particularly with rapid improvement in glucose control) [2] Headaches are accompanied by unexplained weight loss, night sweats, or fever You have a history of migraine and the character of headaches has changed substantially Routine review is appropriate if headaches are mild, improving over time, and responding to simple analgesia and hydration

And once starting the medications, it is equally vital to have regular check ins with your provider, and complete updated information forms when re-ordering each month - rolling subscriptions and an Amazon-esque style of ordering should be red flags when it comes to weight loss medications where your statistics and experience can mean the difference between continuing usage or discontinuing the medications
However, in mice subjected to chronic stress, minocycline can counteract anxio-depressive-like phenotype and stress-induced microglial activation associated with decrease in hippocampal neurogenesis [139]
Aug 1990;55(3):439-53
Among people who stayed on it and reached the full dose, average weight loss was 16.6%